S 529
Capping Prescription Costs Act of 2025
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 14, 2026, 8:39 AM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
The Capping Prescription Costs Act of 2025 aims to limit the amount individuals and families pay for prescription drugs through cost-sharing in health insurance plans. Starting in 2026, health plans would be capped at $2,000 per individual or $4,000 per family annually for prescription drug cost-sharing. The cost-sharing limits will adjust annually based on the Consumer Price Index. This legislation applies to various types of health plans, including those under the Affordable Care Act, Medicare Part D, and employer-sponsored plans, and is codified through amendments to the Patient Protection and Affordable Care Act, the Public Health Service Act, the Employee Retirement Income Security Act, and the Internal Revenue Code.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.